Showing results (1581-1590 of 2,755) with videos related to

Sort By:
Pageof 276
Familial Cancer|June 9, 2009
A high frequent BRCA1 founder mutation identified in the Greenlandic populationTheresa Larriba Harboe, Hans Eiberg, Peder Kern, et al.
Nature Nanotechnology|February 8, 2011
Flexible high-performance carbon nanotube integrated circuitsDong-ming Sun, Marina Y Timmermans, Ying Tian, et al.
Disability and Rehabilitation|May 30, 2009
Arm and hand skills: training preferences after strokeAnnick A A Timmermans, Henk A M Seelen, Richard D Willmann, et al.
Emerging Infectious Diseases|June 23, 2020
Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018-2019Marion de Vries, Liesbeth Claassen, Margreet J M Te Wierik, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 1996
Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST)L Mortelmans, W Vanhecke, D Mertens, et al.
Biology of Sex Differences|December 17, 2016
Sex-specific differences in fetal and infant growth patterns: a prospective population-based cohort studyZoe A Broere-Brown, Esme Baan, Sarah Schalekamp-Timmermans, et al.
Journal of Telemedicine and Telecare|October 17, 2022
Economic evaluation of remote monitoring of patients with an implantable cardiac defibrillator (REMOTE-CIED study)Gimon de Graaf, Ivy Timmermans, Mathias Meine, et al.
Autonomic Neuroscience : Basic & Clinical|April 18, 2006
Region-specific distribution of the P2Y4 receptor in enteric glial cells and interstitial cells of Cajal within the guinea-pig gastrointestinal tractLuc Van Nassauw, Anna Costagliola, Joeri Van Op den Bosch, et al.
BMC Biotechnology|December 5, 2012
Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homingBert R Everaert, Irene Bergwerf, Nathalie De Vocht, et al.
Molecular & Cellular Proteomics : MCP|November 23, 2012
Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancerTeresa Cabezón, Irina Gromova, Pavel Gromov, et al.
Pageof 276